Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism

Journal of Alternative and Complementary Medicine

Volumn 16, Issue 5, 2010, Pages 555-560

  Bertoglio, Kiah ^a,b   Jill James, S ^c   Deprey, Lesley ^b   Brule, Norman ^b   Hendren, Robert L ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UCSF Department of Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; MECOBALAMIN; PLACEBO;

ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HYPERACTIVITY; MALE; OPEN STUDY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; AUTISTIC DISORDER; BIOLOGICAL MARKERS; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GLUTATHIONE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PILOT PROJECTS; VITAMIN B 12; VITAMINS;

EID: 77952569300     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0177     Document Type: Article

References (25)

1. Keller F, Persico AM. The neurobiological context of autism. Mol Neurobiol 2003;28:1-22.
2. Beaudet AL. Is medical genetics neglecting epigenetics? Genet Med 2002;4:399-402.
3. London EA. The environment as an etiologic factor in autism: A new direction for research. Environ Health Perspect 2000;108(suppl 3):401-404.
4. Rice CE, et al. A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol 2007;21:179-190.
5. Bertrand J, et al. Prevalence of autism in a United States population: The Brick Township, New Jersey, investigation. Pediatrics 2001;108:1155-1161.
6. DeStefano F, et al. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: A population-based study in metropolitan Atlanta. Pediatrics 2004;113:259-266.
7. Steinhausen HC, et al. A community survey of infantile autism. J Am Acad Child Psychiatry 1986;25:186-189.
8. Mattson, MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003;26:137-146.
9. Durand P, et al. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001;81:645-672.
10. James SJ, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004;80:1611-1617.
11. James SJ, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006;141B: 947-956.
12. Lord C, et al. Autism diagnostic observation schedule: A standardized observation of communicative and social behavior. J Autism Dev Disord 1989;19:185-212.
13. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994;24:659-685.
14. Stone WL, et al. The Parent Interview for Autism-Clinical Version (PIA-CV): A measure of behavioral change for young children with autism. Autism 2003;7:9-30.
15. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: US Department of Health, Education and Welfare, 1976.
16. Schopler E, et al. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 1980;10:91-103.
17. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test- Revised. Circle Pines, MN: American Guidance Service, 1981.
18. Roid GH. Stanford Binet Intelligence Scales, 5th ed. Rolling Meadows, IL: Riverside Publishing, 2003.
19. Aman MG, et al. The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985;89:485-491.
20. Achenbach T, Edelbrock C. Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Burlington, VT: University Associates in Psychiatry, 1983.
21. Dale PS, Reznick JS, Thal DJ. A Parent Report Measure of Language Development for Three Year Olds. Paper presented at the International Conference on Infant Studies, Atlanta, Georgia, April 1998. 1998.
22. Jones DP. Redox potential of GSH=GSSG couple: Assay and biological significance. Methods Enzymol 2002;348:93-112.
23. Kanazawa S, Herbert V. Total corrinoid, cobalamin (vitamin B12), and cobalamin analogue levels may be normal in serum despite cobalamin in liver depletion in patients with alcoholism. Lab Invest 1985;53:108-110.
24. Shane B, Watson JE, Stokstad EL. Uptake and metabolism of [3H]folate by normal and by vitamin B-12- and methioninedeficient rats. Biochim Biophys Acta 1977;497:241-252.
25. Monsen AL, et al. Cobalamin status and its biochemical markers methylmalonic acid and homocysteine in different age groups from 4 days to 19 years. Clin Chem 2003;49: 2067-2075.